Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy

Objective: Natalizumab is an effective treatment for patients with multiple sclerosis (MS) that is associated with a risk of progressive multifocal leukoencephalopathy (PML). Recommendations were published in 2006 to improve early diagnosis of PML using magnetic resonance imaging (MRI). However, due...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of neurology Vol. 72; no. 5; pp. 779 - 787
Main Authors:	Yousry, Tarek A., Pelletier, Daniel, Cadavid, Diego, Gass, Achim, Richert, Nancy D., Radue, Ernst-Wilhelm, Filippi, Massimo
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2012 Wiley-Liss Wiley Subscription Services, Inc
Subjects:	Adult Antibodies, Monoclonal, Humanized - adverse effects Biological and medical sciences Brain - pathology Female Follow-Up Studies Human immunodeficiency virus Humans Image Processing, Computer-Assisted Investigative techniques, diagnostic techniques (general aspects) Leukoencephalopathy, Progressive Multifocal - chemically induced Leukoencephalopathy, Progressive Multifocal - pathology Magnetic Resonance Imaging Male Medical sciences Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Natalizumab Nervous system Neurology NMR Nuclear magnetic resonance Product Surveillance, Postmarketing Radiodiagnosis. Nmr imagery. Nmr spectrometry Retrospective Studies Time Factors Infection Virus Nervous system diseases Natalizumab Viral disease Central nervous system disease Nuclear magnetic resonance imaging Inflammatory disease Cerebral disorder Progressive multifocal leukoencephalopathy Slow virus
ISSN:	0364-5134, 1531-8249, 1531-8249
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!